HEALTH PROFESSIONAL · SOURCE READING

Rituximab

Source: Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: February 21, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Hairy Cell Leukemia / Treatment Options for Hairy Cell Leukemia

Rituximab can induce durable remissions (with minimal toxic effects), but rarely complete remissions, in patients with multiple relapses or refractory disease after treatment with a purine analogue or interferon.[11,22,25][Level of evidence C3]

Source links and citations

11
22
25
Level of evidence C3

Publication references

Read the original reference and check its publication notices.

PubMed 12816862 · Original source
PubMed 18798112 · Original source
PubMed 35143639 · Original source

Preserved source evidence · Not medical advice